Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Drug combination for treating fatty liver

A composition and fatty liver technology, applied in the direction of drug combination, medical formula, plant raw materials, etc., can solve the problems of viscera dysfunction and other problems, achieve the effect of invigorating function, significant effect of purifying fat, and promoting bile excretion function

Inactive Publication Date: 2015-12-09
黄宇松
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Currently, most urban young people (30-45 years old) eat too much, often drink beer, do little exercise, and spend more time sitting in the office, resulting in organ dysfunction

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0012] Example 1: The pharmaceutical composition is composed of the following components by weight: 8 parts of Bupleurum, 13 parts of Radix Paeoniae Alba, 10 parts of Desmodium, 8 parts of Zhebei, 11 parts of Gallinarum, and 10 parts of Poria cocos , 10 parts of citrus aurantium, 8 parts of turmeric, 12 parts of radish, 8 parts of Cyperus cyperi, 12 parts of salvia miltiorrhiza, 28 parts of astragalus, 8 parts of hawthorn, 10 parts of tangerine peel, 1 part of alum, 5 parts of mint, each serving is 1g.

Embodiment 2

[0013] Example 2: The pharmaceutical composition is composed of the following components by weight ratio, 10 parts of Bupleurum radix, 15 parts of Radix Paeoniae Alba, 8 parts of Desmodium, 10 parts of Zhebei, 10 parts of Gallus gallis, 8 parts of Poria cocos , 10 parts of citrus aurantium, 10 parts of turmeric, 10 parts of radish, 9 parts of Cyperus cyperi, 13 parts of salvia miltiorrhiza, 30 parts of astragalus, 10 parts of hawthorn, 8 parts of tangerine peel, 1 part of alum, 7 parts of mint, each serving is 1g.

Embodiment 3

[0014] Example 3: The pharmaceutical composition is composed of the following components by weight: 12 parts of Bupleurum bupleuri, 18 parts of Radix Paeoniae Alba, 12 parts of Desmodium, 12 parts of Zhebei, 12 parts of Gallus chinensis, and 15 parts of Poria cocos , 15 parts of citrus aurantium, 12 parts of turmeric, 13 parts of radish, 10 parts of Cyperus cyperi, 16 parts of salvia miltiorrhiza, 32 parts of astragalus, 12 parts of hawthorn, 12 parts of tangerine peel, 2 parts of alum, 8 parts of mint, each serving is 1g.

[0015] Decoction method: add water to decoct with the above prescription, the decoction method is the same as the prior art, it should be noted that mint is the last medicine.

[0016] Dosage: One dose a day.

[0017] Therapeutic effect: take 20 patients with fatty liver caused by excessive diet and less exercise, take 30 doses, and cooperate with moderate exercise during the period of taking; B-ultrasound examination on the third day after taking 30 doses...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of treatment of a fatty liver, in particular to a drug combination for treating a fatty liver. The drug combination is prepared from, by weight, 8-12 parts of radix bupleuri, 13-18 parts of white peony roots, 8-12 parts of desmodium, 8-12 parts of Zhejiang fritillary, 10-12 parts of 8-12 parts of chicken's gizzard-membranes, 8-15 parts of poria cocos, 10-15 parts of frutus aurantii immaturus, 8-12 parts of radix curcumae, 10-13 parts of semen raphani, 8-10 parts of rhizoma cyperi, 12-16 parts of roots of red-rooted salvia, 28-32 parts of astragalus mongholicus, 8-12 parts of hawthorns, 8-12 parts of dried tangerine or orange peel, 1-2 parts of alumen and 5-8 parts of mint. The drug combination has the advantages that the whole-body clearing, dredging and facilitating are achieved, both primary and secondary symptoms are eliminated, evil is removed, healthy atmosphere is not damaged, deficiency is tonified, the drug combination is not evil, liver, gall, spleen and stomach dredging is free, body metabolism is normal, and therefore diseases are removed automatically. Thus, the drug combination has a good treatment effect on the fatty liver caused by excessive diet uptake and little exercise.

Description

technical field [0001] The invention relates to the technical field of treating fatty liver, in particular to a pharmaceutical composition for treating fatty liver. Background technique [0002] Fatty liver refers to the pathological changes caused by excessive accumulation of fat in liver cells due to various reasons. Currently, most urban young people (30-45 years old) eat too much, often drink beer, and do less exercise, and often sit in the office, resulting in dysfunction of the viscera. Traditional Chinese medicine believes that: the liver is responsible for the failure of catharsis, gallbladder qi stagnation, oozing fat and turbidity without power, and phlegm turbidity; After a long time, it will become fat and turbid. [0003] In view of this, the applicant conducted in-depth research on the existing technology for the treatment of fatty liver, which resulted in this case. Contents of the invention [0004] The object of the present invention is to provide a pha...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/9066A61P1/16A61K35/57
Inventor 黄宇松
Owner 黄宇松
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com